{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T22:53:34Z","timestamp":1787266414284,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.lanepe.2024.100927","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T17:14:28Z","timestamp":1715793268000},"page":"100927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7466-4892","authenticated-orcid":false,"given":"Jakob L.","family":"Schroevers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke P.","family":"Hoevenaar-Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim B.","family":"Busschers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Van Gool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-8841","authenticated-orcid":false,"given":"Jan Willem","family":"Van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Moll van Charante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lanepe.2024.100927_bib1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"10248","key":"10.1016\/j.lanepe.2024.100927_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the lancet commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100927_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-190474","article-title":"Midlife hypertension and alzheimer's disease: a systematic review and meta-analysis","volume":"71","author":"Lennon","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"10304","key":"10.1016\/j.lanepe.2024.100927_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.lanepe.2024.100927_bib5","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lanepe.2024.100927_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.lanepe.2024.100927_bib7","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jamda.2020.12.019","article-title":"Antihypertensive medication classes and the risk of dementia: a systematic review and network meta-analysis","volume":"22","author":"den Brok","year":"2021","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.lanepe.2024.100927_bib8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"33","key":"10.1016\/j.lanepe.2024.100927_bib9","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.lanepe.2024.100927_bib10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.lanepe.2024.100927_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension","volume":"18","author":"Zhou","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.lanepe.2024.100927_bib12","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100927_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"Ding","year":"2020","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100927_bib14","first-page":"262","article-title":"Antihypertensive medication classes and the risk of dementia over a decade of follow-up","volume":"41","author":"Schroevers","year":"2023","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1016\/j.lanepe.2024.100927_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/WAD.0b013e31819783a4","article-title":"Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress","volume":"23","author":"Richard","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"10.1016\/j.lanepe.2024.100927_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40256-021-00510-9","article-title":"Current and emerging classes of pharmacological agents for the management of hypertension","volume":"22","author":"Ojha","year":"2022","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100927_bib17","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1212\/WNL.0000000000010996","article-title":"Association of angiotensin II-stimulating antihypertensive use and dementia risk: post hoc analysis of the PreDIVA trial","volume":"96","author":"van Dalen","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100927_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.45319","article-title":"Association of antihypertensives that stimulate vs inhibit types 2 and 4 angiotensin II receptors with cognitive impairment","volume":"5","author":"Marcum","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100927_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.49370","article-title":"Association of new use of antihypertensives that stimulate vs inhibit type 2 and 4 angiotensin II receptors with dementia among medicare beneficiaries","volume":"6","author":"Marcum","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanepe.2024.100927_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S389598","article-title":"Completeness and representativeness of the pharmo general practitioner (GP) data: a comparison with national statistics","volume":"15","author":"Overbeek","year":"2023","journal-title":"Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.lanepe.2024.100927_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.lanepe.2024.100927_bib22","author":"Therneau"},{"issue":"7","key":"10.1016\/j.lanepe.2024.100927_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21037\/atm.2018.02.12","article-title":"Time-varying covariates and coefficients in Cox regression models","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100927_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13293-019-0247-5","article-title":"Sex differences in the metabolic effects of the renin-angiotensin system","volume":"10","author":"White","year":"2019","journal-title":"Biol Sex Differ"},{"issue":"27","key":"10.1016\/j.lanepe.2024.100927_bib26","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.lanepe.2024.100927_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5060","article-title":"Interpreting and comparing risks in the presence of competing events","volume":"349","author":"Wolkewitz","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100927_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/sim.8399","article-title":"A\u00a0review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model","volume":"39","author":"Austin","year":"2020","journal-title":"Stat Med"},{"key":"10.1016\/j.lanepe.2024.100927_bib29","series-title":"R: a language and environment for statistical computing","author":"Team RC","year":"2020"},{"key":"10.1016\/j.lanepe.2024.100927_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnagi.2013.00017","article-title":"Pathology and pathogenesis of vascular cognitive impairment-a critical update","volume":"5","author":"Jellinger","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.lanepe.2024.100927_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105515","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: a meta-analysis","volume":"166","author":"Scotti","year":"2021","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.lanepe.2024.100927_bib32","first-page":"715","article-title":"Antihypertensive agents and incident alzheimer's disease: a systematic review and meta-analysis of observational studies","volume":"9","author":"Adesuyan","year":"2022","journal-title":"J\u00a0Prev Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100927_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-190362","article-title":"The relationship between the use of antihypertensive drugs and the incidence of dementia in general practices in Germany","volume":"70","author":"Bohlken","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2024.100927_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/clc.23591","article-title":"Blood pressure reduction and anti-hypertensive treatment choice: a post-hoc analysis of the SPRINT trial","volume":"44","author":"Ferreira","year":"2021","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100927_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147601","article-title":"Panethnic differences in blood pressure in europe: a systematic review and meta-analysis","volume":"11","author":"Modesti","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100927_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/HJH.0000000000000428","article-title":"Socioeconomic status and hypertension: a meta-analysis","volume":"33","author":"Leng","year":"2015","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.lanepe.2024.100927_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2018.02.027","article-title":"Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: a meta-analysis of prospective studies","volume":"671","author":"Hussain","year":"2018","journal-title":"Neurosci Lett"},{"issue":"8","key":"10.1016\/j.lanepe.2024.100927_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11906-016-0673-2","article-title":"Relationship between antihypertensive medications and cognitive impairment: part II. Review of physiology and animal studies","volume":"18","author":"Peters","year":"2016","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100927_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"Rouch","year":"2015","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.lanepe.2024.100927_bib40","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","article-title":"Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series","volume":"69","author":"Hajjar","year":"2012","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.lanepe.2024.100927_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002235","article-title":"Dementia incidence trend over 1992-2014 in the Netherlands: analysis of primary care data","volume":"14","author":"van Bussel","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanepe.2024.100927_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12875-014-0176-7","article-title":"Do practice characteristics explain differences in morbidity estimates between electronic health record based general practice registration networks?","volume":"15","author":"van den Dungen","year":"2014","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.lanepe.2024.100927_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101862","article-title":"SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in The Netherlands: an external validation study","volume":"57","author":"Kist","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"8","key":"10.1016\/j.lanepe.2024.100927_bib44","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/HJH.0000000000001777","article-title":"Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis","volume":"36","author":"Thomopoulos","year":"2018","journal-title":"J\u00a0Hypertens"}],"updated-by":[{"DOI":"10.1016\/j.lanepe.2024.101132","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T10:50:11Z","timestamp":1732099811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":43,"alternative-id":["S2666776224000942"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100927","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.lanepe.2024.101132","asserted-by":"object"}]},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100927"}}